Abstract
Advanced drug delivery systems present indubitable advantages for drug administration. During the past three decades, new approaches for the development of new carriers for this topic have been suggested. This led to explosion of publication activity in the area. This article reviews briefly the history of the topic and focuses on general concepts in the issue. One of the most crucial properties of advanced delivery systems is their ability to be well controlled in terms of a carrier structure which is responsible for an optimal drug release. Here we describe new polymerization technologies which consider this particular aspect. A special attention is paid to the preparation of materials by LRP (Living Radical Polymerization) and perspectives of its practical application to the treatment of single diseases. Due to the epidemic scale of Diabetes mellitus, novel drug delivery systems play an important role in and are highly relevant for improved treatment of worldwide permanently growing sub-population of diabetic patients. Type 1 is the insulin-dependent diabetes which accounts for 5 till 10 percent of the whole pool of diabetic cases and currently attracts main attention in research activity devoted to the development of advanced drug delivery systems. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease.
Keywords: Living radical polymerization, drug delivery systems, cells encapsulation, Diabetes mellitus
Infectious Disorders - Drug Targets
Title: New Approaches in Drug Delivery Systems: Application for Diabetes Treatment
Volume: 8 Issue: 2
Author(s): Jorge F. J. Coelho, Paula Ferreira and Maria H. Gil
Affiliation:
Keywords: Living radical polymerization, drug delivery systems, cells encapsulation, Diabetes mellitus
Abstract: Advanced drug delivery systems present indubitable advantages for drug administration. During the past three decades, new approaches for the development of new carriers for this topic have been suggested. This led to explosion of publication activity in the area. This article reviews briefly the history of the topic and focuses on general concepts in the issue. One of the most crucial properties of advanced delivery systems is their ability to be well controlled in terms of a carrier structure which is responsible for an optimal drug release. Here we describe new polymerization technologies which consider this particular aspect. A special attention is paid to the preparation of materials by LRP (Living Radical Polymerization) and perspectives of its practical application to the treatment of single diseases. Due to the epidemic scale of Diabetes mellitus, novel drug delivery systems play an important role in and are highly relevant for improved treatment of worldwide permanently growing sub-population of diabetic patients. Type 1 is the insulin-dependent diabetes which accounts for 5 till 10 percent of the whole pool of diabetic cases and currently attracts main attention in research activity devoted to the development of advanced drug delivery systems. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease.
Export Options
About this article
Cite this article as:
Coelho F. J. Jorge, Ferreira Paula and Gil H. Maria, New Approaches in Drug Delivery Systems: Application for Diabetes Treatment, Infectious Disorders - Drug Targets 2008; 8 (2) . https://dx.doi.org/10.2174/187152608784746556
DOI https://dx.doi.org/10.2174/187152608784746556 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
Call for Papers in Thematic Issues
New Frontiers in Infectious Disease Research: Small-Molecule Probes and Biomarker Identification
The biological relevance of small-molecule chemical probes targeting a disease model is crucial in the early stages of drug discovery. The integration of omics technologies such as genomics, proteomics, metabolomics, immunomic, and cellular levels has greatly enhanced the ability to identify novel biomarkers and understand the complex interactions between pathogens ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Long-term Exposure to Cadmium in Food and Cigarette Smoke, Liver Effects and Hepatocellular Carcinoma
Current Drug Metabolism Investigating Mitochondrial Dysfunction to Increase Drug Safety in the Pharmaceutical Industry
Current Drug Targets Epidemiology of Hypertension and Diabetes Mellitus in Latin America
Current Hypertension Reviews A Systematic Review of the Potential Herbal Sources of Future Drugs Effective in Oxidant-Related Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment
Current Pharmaceutical Design Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Intracellular Location of KATP Channels and Sulphonylurea Receptors in the Pancreatic β-cell: New Targets for Oral Antidiabetic Agents
Current Medicinal Chemistry Mass Spectrometry in Doping Control Analysis
Current Organic Chemistry Diabetic Cardiomyopathy and Oxidative Stress: Role of Antioxidants
Cardiovascular & Hematological Agents in Medicinal Chemistry Molecular Structural Characteristics of Estrogen Receptor Modulators as Determinants of Estrogen Receptor Selectivity
Mini-Reviews in Medicinal Chemistry GSK-3 Inhibitors: Discoveries and Developments
Current Medicinal Chemistry Advances and Barriers in Mammalian Cell Encapsulation for Treatment of Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Inflammatory Biomarkers in Cardiovascular Therapeutics
Current Medicinal Chemistry Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Current Pharmaceutical Design GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Transcriptome-wide Association Study Identifies Genetically Dysregulated Genes in Diabetic Neuropathy
Combinatorial Chemistry & High Throughput Screening Influence of Glycation of Plasma Proteins in Diabetes on the Binding Interaction with Polyphenols
Current Drug Metabolism Low 25OH Vitamin D2 Levels Found in Untreated Alzheimer’s Patients, Compared to Acetylcholinesterase-Inhibitor Treated and Controls
Current Alzheimer Research Editorial (Thematic Issue: Active Pregnancy - Benefits and Recommendations of Physical Activity and a Healthy Lifestyle Throughout Pregnancy and Postpartum)
Current Women`s Health Reviews Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets